Healthcare -
Biotechnology - NASDAQ - US
$ 1.27
1.6 %
$ 145 M
Market Cap
-0.77
P/E
FATE - TOTAL EQUITY
Total Equity FATE - Fate Therapeutics, Inc.
368 M
LAST VALUE
-26.33%
2 YEAR CAGR
18.08%
5 YEAR CAGR
21.90%
10 YEAR CAGR